• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改善患有罕见骨病(RBD)人群的护理途径:首届 RBD 峰会的成果。

Improving care pathways for people living with rare bone diseases (RBDs): outcomes from the first RBD Summit.

机构信息

Osteoporosis and Bone Metabolism Unit, Department of Endocrinology, Singapore General Hospital, DUKE NUS Medical School, Singapore, Singapore.

ANDO Portugal, CHRC, University of Évora, European Reference Network On Rare Bone Diseases, Évora, Portugal.

出版信息

Osteoporos Int. 2023 Aug;34(8):1301-1310. doi: 10.1007/s00198-023-06791-x. Epub 2023 Jun 9.

DOI:10.1007/s00198-023-06791-x
PMID:37294334
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10382343/
Abstract

INTRODUCTION

Rare bone diseases (RBDs) are a heterogenous group of disorders that are poorly understood and challenging to treat. This creates a plethora of unmet needs for people with RBDs as well as their families and care providers, including diagnostic delays, limited access to expert care, and a lack of specialized treatments. The RBD Summit, which took place across 2 days in November 2021, was a virtual meeting of 65 RBD experts from clinical, academic, and patient communities as well as the pharmaceutical industry. The first meeting of its kind, the RBD Summit aimed to facilitate dialog and information exchange between delegates to advance knowledge and awareness of RBDs and improve patient outcomes.

METHODS

Key challenges were discussed, and actions for overcoming them were proposed, including how obstacles to diagnosis can be overcome by (a) improving awareness of RBDs, (b) the implementation of a person-centered care pathway, and (c) how to narrow the communication gap between patients and healthcare professionals.

RESULTS

Agreed actions were categorized as short term and long term, and priorities determined.

CONCLUSION

In this position paper, we provide an overview of key discussions from the RBD Summit, summarize the subsequent action plan, and discuss the next steps in this continued collaboration.

摘要

简介

罕见骨骼疾病(RBD)是一组异质性疾病,其发病机制尚未完全阐明,治疗方法也颇具挑战性。这给 RBD 患者及其家属和医护人员带来了诸多未满足的需求,包括诊断延迟、获得专家护理的机会有限以及缺乏专门的治疗方法。2021 年 11 月,为期两天的 RBD 峰会以虚拟会议的形式召集了来自临床、学术和患者社区以及制药行业的 65 名 RBD 专家。作为同类会议中的首次会议,RBD 峰会旨在促进代表之间的对话和信息交流,以增进对 RBD 的认识和了解,并改善患者的治疗结局。

方法

会上讨论了主要挑战,并提出了克服这些挑战的行动方案,包括如何通过(a)提高对 RBD 的认识、(b)实施以患者为中心的护理途径以及(c)如何缩小医患之间的沟通差距来克服诊断障碍。

结果

商定的行动方案分为短期和长期,并确定了优先事项。

结论

在这份立场文件中,我们概述了 RBD 峰会的主要讨论内容,总结了随后的行动计划,并讨论了在这一持续合作中的下一步行动。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/059c/10382343/711e4188292b/198_2023_6791_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/059c/10382343/43ca73e42387/198_2023_6791_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/059c/10382343/711e4188292b/198_2023_6791_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/059c/10382343/43ca73e42387/198_2023_6791_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/059c/10382343/711e4188292b/198_2023_6791_Fig2_HTML.jpg

相似文献

1
Improving care pathways for people living with rare bone diseases (RBDs): outcomes from the first RBD Summit.改善患有罕见骨病(RBD)人群的护理途径:首届 RBD 峰会的成果。
Osteoporos Int. 2023 Aug;34(8):1301-1310. doi: 10.1007/s00198-023-06791-x. Epub 2023 Jun 9.
2
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
3
[Measures to improve the health situation of patients with rare diseases in Germany. A comparison with the National Action Plan].[德国改善罕见病患者健康状况的措施。与国家行动计划的比较]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Oct;57(10):1216-23. doi: 10.1007/s00103-014-2040-2.
4
Bridging the Gap between Health and Social Care for Rare Diseases: Key Issues and Innovative Solutions.弥合罕见病健康与社会关怀之间的差距:关键问题与创新解决方案。
Adv Exp Med Biol. 2017;1031:605-627. doi: 10.1007/978-3-319-67144-4_32.
5
Consanguineous marriage and rare bleeding disorders.血缘婚姻与罕见的出血性疾病。
Expert Rev Hematol. 2021 May;14(5):467-472. doi: 10.1080/17474086.2021.1923476. Epub 2021 May 10.
6
Current challenges and opportunities in the care of patients with fibrodysplasia ossificans progressiva (FOP): an international, multi-stakeholder perspective.纤维性骨发育不良进展性(FOP)患者护理方面的当前挑战与机遇:国际多利益相关方视角。
Orphanet J Rare Dis. 2022 Apr 18;17(1):168. doi: 10.1186/s13023-022-02224-w.
7
Potential of the Community Counts registry to characterize rare bleeding disorders.社区计数登记册在稀有出血性疾病特征描述中的潜力。
Haemophilia. 2019 Nov;25(6):1045-1050. doi: 10.1111/hae.13847. Epub 2019 Sep 11.
8
[Interdisciplinary care path and potential IT support for people with rare diseases in Germany].[德国罕见病患者的跨学科护理路径及潜在的信息技术支持]
Z Evid Fortbild Qual Gesundhwes. 2021 Oct;165:68-76. doi: 10.1016/j.zefq.2021.06.004. Epub 2021 Sep 3.
9
The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.医院环境中患者与护士以患者为中心的沟通体验:一项定性系统评价方案
JBI Database System Rev Implement Rep. 2015 Jan;13(1):76-87. doi: 10.11124/jbisrir-2015-1072.
10
Establishment of a bleeding score as a diagnostic tool for patients with rare bleeding disorders.建立出血评分作为罕见出血性疾病患者的诊断工具。
Thromb Res. 2016 Dec;148:128-134. doi: 10.1016/j.thromres.2016.11.008. Epub 2016 Nov 15.

引用本文的文献

1
Artificial intelligence for diagnosing rare bone diseases: a global survey of healthcare professionals.用于诊断罕见骨病的人工智能:医疗保健专业人员的全球调查。
Orphanet J Rare Dis. 2025 Jul 16;20(1):365. doi: 10.1186/s13023-025-03875-1.
2
Update on the medical management of fibrous dysplasia of the bone.骨纤维异常增殖症的药物治疗进展
Ther Adv Endocrinol Metab. 2025 Jun 18;16:20420188251347350. doi: 10.1177/20420188251347350. eCollection 2025.
3
XLH Matters: an evolving programme to discuss new advances and share clinical experiences to improve patient outcomes.

本文引用的文献

1
Nosology of genetic skeletal disorders: 2023 revision.遗传骨骼疾病分类学:2023 修订版。
Am J Med Genet A. 2023 May;191(5):1164-1209. doi: 10.1002/ajmg.a.63132. Epub 2023 Feb 13.
2
Why is misdiagnosis more likely among some people with rare diseases than others? Insights from a population-based cross-sectional study in China.为什么一些罕见病患者比其他人更容易误诊?基于中国人群的横断面研究的见解。
Orphanet J Rare Dis. 2020 Oct 28;15(1):307. doi: 10.1186/s13023-020-01587-2.
3
The Rare Bone Disease TeleECHO Program: Leveraging Telehealth to Improve Rare Bone Disease Care.
XLH 相关事宜:一项不断发展的计划,旨在讨论新进展并分享临床经验以改善患者治疗效果。
Orphanet J Rare Dis. 2025 Feb 3;19(Suppl 2):497. doi: 10.1186/s13023-024-03387-4.
罕见骨病远程 echO 项目:利用远程医疗改善罕见骨病护理。
Curr Osteoporos Rep. 2020 Aug;18(4):344-349. doi: 10.1007/s11914-020-00595-2.
4
The evolving therapeutic landscape of genetic skeletal disorders.遗传骨骼疾病治疗领域的不断发展。
Orphanet J Rare Dis. 2019 Dec 30;14(1):300. doi: 10.1186/s13023-019-1222-2.
5
Chronic non-bacterial osteomyelitis: a comparative study between children and adults.慢性非细菌性骨髓炎:儿童与成人的对比研究。
Pediatr Rheumatol Online J. 2019 Jul 23;17(1):49. doi: 10.1186/s12969-019-0353-2.
6
The FAIR Guiding Principles for scientific data management and stewardship.科学数据管理和保存的 FAIR 指导原则。
Sci Data. 2016 Mar 15;3:160018. doi: 10.1038/sdata.2016.18.
7
Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva.进行性骨化性纤维发育不良中诊断错误导致的医源性损害。
Pediatrics. 2005 Nov;116(5):e654-61. doi: 10.1542/peds.2005-0469. Epub 2005 Oct 17.